PTSD Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
For men:
- People who identify as a man
- People who have been sent by a court to attend an intimate partner violence (IPV) intervention program in Washington state
- People who agree to allow the research team to contact their intimate partner(s) to collect information for the study
For women:
- People who identify as a woman
- People who are, or were, an intimate partner of a man participating in this trial, where an incident of intimate partner violence occurred
Who may not be able to join:
- People who are currently experiencing active psychosis (serious mental health symptoms affecting their grip on reality) in a way that may make it difficult to take part in group sessions (confirm with trial site)
- People who are currently expressing strong thoughts of suicide or harming others that would require a hospital stay
- People who are not able to speak English well enough to participate
- People who are jailed or imprisoned at any point after joining the study
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Casey Taft, PhD, BU School of Medicine and National Center for PTSD
Phone: 978-380-0576
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
IPV assessment; Psychological IPV assessment; Post Traumatic Stress Disorder (PTSD) symptoms; Alcohol use; Alexithymia assessment
Can't join this trial?
Data last synced from ClinicalTrials.gov: 22 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.